We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

66 hedge funds and large institutions have $88.5M invested in Cardiff Oncology in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 20 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

375% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 8

300% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 5

93% more capital invested

Capital invested by funds: $45.8M → $88.5M (+$42.7M)

83% more funds holding

Funds holding: 36 → 66 (+30)

69% less call options, than puts

Call options by funds: $407K | Put options by funds: $1.33M

Holders
66
Holders Change
+30
Holders Change %
+83.33%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
38
Increased
20
Reduced
5
Closed
8
Calls
$407K
Puts
$1.33M
Net Calls
-$924K
Net Calls Change
-$748K

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$5.72M
2
Goldman Sachs
Goldman Sachs
New York
+$3.05M
3
BM
Bridger Management
New York
+$2.96M
4
EI
EAM Investors
California
+$2.86M
5
State Street
State Street
Massachusetts
+$1.86M

Top Sellers

1
TCM
Tekla Capital Management
Massachusetts
-$4.43M
2
RCM
RA Capital Management
Massachusetts
-$4.05M
3
ACA
Avoro Capital Advisors
New York
-$2.21M
4
DADC
D.A. Davidson & Co
Montana
-$1.16M
5
UBS Group
UBS Group
Switzerland
-$334K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$541K +$525K +740 New
Northern Trust
27
Northern Trust
Illinois
$533K +$194K +273 +60%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$453K +$440K +620 New
MSTVIM
29
Messner & Smith Theme Value Investment Management
California
$390K -$10.6K -15 -3%
GGHC
30
Gilder Gagnon Howe & Co
New York
$384K +$373K +526 New
PP
31
PDT Partners
New York
$369K +$357K +504 New
TA
32
Teachers Advisors
New York
$364K +$353K +498 New
Charles Schwab
33
Charles Schwab
California
$359K +$348K +491 New
CS
34
Credit Suisse
Switzerland
$257K +$249K +351 New
WMSA
35
Weiss Multi-Strategy Advisers
New York
$254K -$222K -313 -47%
RHBC
36
R.H. Bluestein & Co
Michigan
$254K +$247K +348 New
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$206K +$200K +282 New
MLICM
38
Metropolitan Life Insurance Company (MetLife)
New York
$193K +$187K +264 New
BA
39
BlackRock Advisors
Delaware
$171K +$129K +182 +350%
NFA
40
Nationwide Fund Advisors
Ohio
$160K +$155K +219 New
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$159K +$155K +218 New
Bank of Montreal
42
Bank of Montreal
Ontario, Canada
$146K +$87.2K +123 +162%
AIG
43
American International Group
New York
$145K +$141K +199 New
VOYA Investment Management
44
VOYA Investment Management
Georgia
$133K +$129K +182 New
CC
45
Callan Capital
California
$115K +$111K +157 New
EEG
46
E.E. Geduld
$102K +$98.6K +139 New
HCM
47
Highlander Capital Management
New Jersey
$81K +$78.7K +111 New
SO
48
STRS Ohio
Ohio
$79K +$76.6K +108 New
NPC
49
National Planning Corporation
California
$59K – – –
WAM
50
Wolverine Asset Management
Illinois
$57K +$55.3K +78 New
1
2
3

CRDF Hedge Fund Activity: Q2 2015 in Review

66 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q2 2015, worth a combined $88.5M — up 93% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new CRDF positions and 8 closed out — a net gain of 30 holders — while 20 added to existing stakes and 5 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $5.72M. The largest seller was Tekla Capital Management, exiting entirely with an estimated $4.43M sold.

  • 66 institutional investors held Cardiff Oncology (CRDF) as of Q2 2015, up from 36 in Q1 2015.
  • Funds reported $88.5M of Cardiff Oncology stock for Q2 2015, up 93% quarter-over-quarter.
  • 38 funds opened new Cardiff Oncology positions in Q2 2015 and 8 closed out, a net change of +30 holders.
  • The largest Cardiff Oncology buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $5.72M added.
  • The largest Cardiff Oncology seller in Q2 2015 was Tekla Capital Management, an estimated $4.43M sold.

Based on aggregated 13F filings for Q2 2015.